$ORMP - let’s get this straight a bunch of insider activity. Shares being granted and purchased by executives on the eve of FDA Phase 2 trials being wrapped up. Buying and granting is a lot better than selling right now. Also notice options being offered at 13.89/share. The upside here is rather large. Continuing to hold.